Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • France
    • +34 96 390 53 10 Request Information
    • +34 96 390 53 10 Request Information
    FranceFrance
    • France
      • Part of brands: |
        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        Genomics Precision Diagnostic > Metabolic Precision Panel > Methylmalonic Aciduria Precision Panel

        Methylmalonic Aciduria Precision Panel

        Methylmalonic Aciduria/Acidemia (MMA) is an autosomal recessive disorder of the amino acid metabolism with a defect localized in the conversion of methylmalonyl-coenzyme A (CoA) into succinyl-CoA. 
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Methylmalonic Aciduria/Acidemia (MMA) is an autosomal recessive disorder of the amino acid metabolism with a defect localized in the conversion of methylmalonyl-coenzyme A (CoA) into succinyl-CoA. The body is therefore unable to process certain proteins and lipids properly. This causes an accumulation of methylmalonic acid in the organisms which manifests in the form of neurologic symptoms such as seizures, encephalopathy, and stroke. It is a lethal, severe heterogeneous disorder involving methylmalonate and cobalamin metabolism with poor prognosis. This disorder can be identified isolated or combined with other organic acidemias. 

        • The Igenomix Methylmalonic Aciduria Precision Panel can be used to make an accurate and directed diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

        Indication

        • The Igenomix Methylmalonic Aciduria/Acidemia Precision Panel is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: 
          • Vomiting 
          • Dehydration 
          • Lethargy 
          • Seizures 
          • Recurrent infections 
          • Progressive encephalopathy 
          • Hypotonia 
          • Developmental delay 
          • Hepatomegaly 
          • Intellectual disability  

        Clinical Utility

        The clinical utility of this panel is: 

        • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
        • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient. 
        • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
        • Improvement of delineation of genotype-phenotype correlation. 

        Genes & Diseases

        See all genes and diseases

        GENE 

        OMIM DISEASES 

        INHERITANCE* 

        % GENE COVERAGE (20X) 

        HGMD** 

        ABCD4 

        Methylmalonic Aciduria
        And 
        Homocystinuria 

        AR 

        100 

        8 of 8 

        ACSF3 

        Combined Malonic And
        Methylmalonic Aciduria
         

        AR 

        100 

        27 of 27 

        CCN6 

        Progressive 
        Pseudorheumatoid
         Arthropathy Of Childhood 

        AR 

        100 

        NA of NA 

        CD320 

        Methylmalonic
        Aciduria
         

        AR 

        89 

        2 of 2 

        HCFC1 

        Methylmalonic 
        Acidemia And 
        Homocysteinemia,
        X-linked
        Non-Syndromic
        Intellectual
        Disability
         

        X,XR,G 

        99.81 

        NA of NA 

        LMBRD1 

        Methylmalonic 
        Aciduria And
        Homocystinuria 

        AR 

        99.88 

        8 of 8 

        MCEE 

        Methylmalonyl-CoA 
        Epimerase
         Deficiency 

        AR 

        100 

        5 of 6 

        MLYCD 

        Malonyl-CoA Decarboxylase 
        Deficiency 

        AR 

        93.84 

        32 of 40 

        MMAA 

        Methylmalonic 
        Aciduria
         

        AR 

        99.98 

        77 of 77 

        MMAB 

        Methylmalonic 
        Aciduria
         

        AR 

        99.52 

        43 of 43 

        MMACHC 

        Methylmalonic 
        Aciduria
        And 
        Homocystinuria 

        AR 

        99.97 

        105 of 105 

        MMADHC 

        Methylmalonic 
        Aciduria
        And 
        Homocystinuria 

        AR 

        99.63 

        20 of 20 

        MMUT 

        Methylmalonic
        Aciduria Due To 
        Methylmalonyl-CoA
        Mutase Deficiency
         

        AR 

        99.97 

        NA of NA 

        MTR 

        Methylcobalamin 
        Deficiency,
        Folate-Sensitive
        Neural Tube
        Defects
         

        AR 

        99.94 

        42 of 45 

        PRDX1 

        Methylmalonic 
        Aciduria And 
        Homocystinuria 

        AR 

        100 

        3 of 3 

        SUCLA2 

        Mitochondrial
        DNA Depletion
        Syndrome (
        Encephalomyopathic 
        With Or Without Methylmalonic
        Aciduria)
         

        AR 

        100 

        27 of 27 

        SUCLG1 

        Mitochondrial DNA Depletion
        Syndrome (
        Encephalomyopathic
         Type With
        Methylmalonic
        Aciduria)
         

        AR 

        100 

        34 of 34 

        TCN2 

        Transcobalamin 
        Deficiency 

        AR 

        100 

        25 of 27 

         * Inheritance: AD: Autosomal Dominant; AR: Autosomal Recessive; X: X linked; XLR: X linked Recessive; Mi: Mitochondrial; Mu: Multifactorial 

        ** HGMD: Number of clinically relevant mutations according to HGMD 

        Methodology

        References

        See scientific referrals

        Sloan, J. L., Johnston, J. J., Manoli, I., Chandler, R. J., Krause, C., Carrillo-Carrasco, N., Chandrasekaran, S. D., Sysol, J. R., O’Brien, K., Hauser, N. S., Sapp, J. C., Dorward, H. M., Huizing, M., NIH Intramural Sequencing Center Group, Barshop, B. A., Berry, S. A., James, P. M., Champaigne, N. L., de Lonlay, P., Valayannopoulos, V., … Venditti, C. P. (2011). Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. Nature genetics, 43(9), 883–886. https://doi.org/10.1038/ng.908 

         Matsui, S. M., Mahoney, M. J., & Rosenberg, L. E. (1983). The natural history of the inherited methylmalonic acidemias. New England Journal of Medicine, 308(15), 857-861. doi:10.1056/nejm198304143081501 

        Zhou, X., Cui, Y., & Han, J. (2018). Methylmalonic acidemia: Current status and research priorities. Intractable & rare diseases research, 7(2), 73–78. https://doi.org/10.5582/irdr.2018.01026 

        Deodato, F., Boenzi, S., Santorelli, F. M., & Dionisi-Vici, C. (2006). Methylmalonic and Propionic Aciduria. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C(2), 104-112. doi:10.1002/ajmg.c.30090 

        Miousse, I. R., Watkins, D., Coelho, D., Rupar, T., Crombez, E. A., Vilain, E., . . . Rosenblatt, D. S. (2009). Clinical and molecular heterogeneity in patients with the cbld inborn error of cobalamin metabolism. The Journal of Pediatrics, 154(4), 551-556. doi:10.1016/j.jpeds.2008.10.043 

        Carrillo-Carrasco, N., Chandler, R. J., & Venditti, C. P. (2011). Combined methylmalonic acidemia And homocystinuria, cblC type. I. Clinical Presentations, diagnosis and management. Journal of Inherited Metabolic Disease, 35(1), 91-102. doi:10.1007/s10545-011-9364-y 

        BROCHURE

        Download

        Request Information


        • reCAPTCHA demo: Simple page

        Fertilité

        Fertilité
        Éviter les maladies génétiques

        Test prénatal non-invasif

        Pour voir le certificat d'accréditation, l'annexe technique associée et la liste des tests accrédités, cliquez sur ce lien.

        Nos services

        Nos services
        Patients
        D'envoyer les échantillons
        Manuel d'utilisateur

        À propos d’Igenomix

        À propos d’Igenomix
        Igenomix dans le monde
        Quality
        Work with us

        SUIVRE IGENOMIX

          + 96 390 53 10
        Écrivez-nous
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        France

        [2021] © Igenomix Politique de confidentialité Politique de qualité Note juridique Politique de cookiesActualités et presse 

        Demander des informations


        • reCAPTCHA demo: Simple page

        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        • France
        • +34 96 390 53 10 Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        France
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.